Nivolumab(oesophageal carcinoma or gastroesophageal junction carcinoma): Injection concentrate for I.V. infusion 40 mg in 4 mL, Injection concentrate for I.V. infusion 100 mg in 10 mL; Opdivo®
Page last updated: 11 November 2022
Page last updated: 11 November 2022
© Commonwealth of Australia
ABN: 83 605 426 759